Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications

NCT01415115 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2011-08-11

No results posted yet for this study

Summary

The trial is designed as a feasibility study to determine the correlation of noninvasive measurements of AGE with the SCOUT device to diabetes complications.

Conditions

Sponsors & Collaborators

  • Medstar Health Research Institute

    collaborator OTHER
  • VeraLight, Inc.

    lead INDUSTRY

Principal Investigators

  • Robert Ratner, MD · MedStar Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01415115 on ClinicalTrials.gov